Hormones: all 321 studies that test it

Page 1 of 4. Open to participants first (22), then studies with results posted, then the rest; newest registration first within each.

• Comparative Efficacy of Antioxidants Alone Versus Combined Therapy With SERMs or FSH in Normogonadotropic Idiopathic OAT Patients: A Randomized Controlled TrialNot yet recruitingNCT07862725Phase 4
• Corticotropin for Behçet's Disease: A Multicenter Randomized Controlled TrialAcronym.Not yet recruitingNCT07833163Phase 2
• Post-Prandial Carbohydrate Metabolism in Individuals With and Without Post-Bariatric Surgery Hypoglycemia (PBH)RecruitingNCT07818707Phase 4
• Somatostatin Plus Clear Liquid Diet Versus Diverting Stoma in Patients With Rectal Cancer Undergoing Ultra-Low Anterior ResectionRecruitingNCT07605611Not applicable
• Pancreatic Polypeptide as a Modulator of Amylin- Induced Satiety in Healthy HumansRecruitingNCT07506369Not applicable
• The Postprandial Hypo-Avoid StudyRecruitingNCT07427251Phase 4
• Effects of Terlipressin and Somatostatin on Portal Pressure in Patients Undergoing Living Donor Liver TransplantationRecruitingNCT07304466Not applicable
• Studies of Insulin and Glucagon Action in the LiverNot yet recruitingNCT07300982Phase 1/2
• The Effects of Glucagon on Renal Regional Blood Flow in Humans Measured by Magnetic Resonance.Not yet recruitingNCT06872060Not applicable
• Effects of LH and FSH on Metabolic Regulation in Cumulus CellsRecruitingNCT06803199Not applicable
• Human Models of Selective Insulin Resistance: Pancreatic ClampNot yet recruitingNCT06558422Phase 1
• Pasireotide as Maintenance Treatment in Synovial Sarcoma and Desmoplastic Small Round Cell TumorRecruitingNCT06456359Phase 2
• Regional Lipolysis and Adipocyte Lipolysis Protein StimulationRecruitingNCT06416969Early Phase 1
• Use of Pulsatile Intravenous FSH to Mitigate Reprometabolic SyndromeRecruitingNCT06414096Phase 1
• A Study of Pasireotide in People With ProlactinomaRecruitingNCT06295952Phase 2
• Cortical Excitability in West Syndrome Using Transcranial Magnetic StimulationRecruitingNCT06201897Phase 2/3
• Study of Adrenocorticotropic Hormone on Children With Frequent Relapse or Steroid-dependent Nephrotic Syndrome: a Prospective, Multicenter, Randomized，Open-label Clinical Trial.RecruitingNCT06079788Phase 3
• Aspiration of Duodenopancreatic Juice After Secretin Stimulation vs Endoscopic Aspiration for Molecular Analysis of Intraductal Papillary Mucinous Intraductal Neoplasia.RecruitingNCT05914077Phase 3
• Imaging Biomarkers of Pancreatic Function and DiseaseEnrolling by invitationNCT05659147Phase 4
• Relative Contributions of Predictors of Hyperandrogenism in Older vs. Young Women With PCOSRecruitingNCT03905603Early Phase 1
• NeSST2: The Development of a Noninvasive Short Synacthen TestRecruitingNCT03514589Phase 2
• A Clinical Study to Evaluate the Potential Role of ACTH Gel in Patients With ScleritisRecruitingNCT03465111Phase 2
• The Effects of Glucagon on Hepatic MetabolismCompletedNCT05500586Phase 1/2Results posted
• Glucagon and Advanced HCL System to Prevent Exercise-Induced Hypoglycaemia in People With Type 1 DiabetesCompletedNCT05379686Not applicableResults posted
• A Study of Nasal Glucagon (LY900018) in Pediatric Participants With Type 1 DiabetesCompletedNCT04992312Phase 1Results posted
• Impact of Acthar on Everyday Life of Participants With Severe KeratitisCompletedNCT04169061Phase 4Results posted
• The Effect of Glucagon on Rates of Hepatic Mitochondrial Oxidation in Man Assessed by PINTACompletedNCT03965130Phase 1Results posted
• G-Pen Compared to Glucagen Hypokit for Severe Hypoglycemia Rescue in Adults With Type 1 DiabetesCompletedNCT03738865Phase 3Results posted
• Safety and Effectiveness of Acthar Gel for Inflammation of the Eye's Uvea (Middle Layer)TerminatedNCT03656692Phase 4Results posted
• Glucagon Infusion in T1D Patients With Recurrent Severe Hypoglycemia: Effects on Counter-Regulatory ResponsesTerminatedNCT03490942Phase 2Results posted
• G-Pen™ Compared to Lilly Glucagon for Hypoglycemia Rescue in Adults With Type 1 DiabetesCompletedNCT03439072Phase 3Results posted
• A Study of Nasal Glucagon (LY900018) in Japanese Participants With Diabetes MellitusCompletedNCT03421379Phase 3Results posted
• Is Adrenal Insufficiency Under-diagnosed in Hospitalized Cirrhosis Patients?CompletedNCT03368066Phase 3Results posted
• A Study of Nasal Glucagon in Participants With Type 1 Diabetes MellitusCompletedNCT03339453Phase 1Results posted
• Acthar Gel in Participants With Pulmonary SarcoidosisCompletedNCT03320070Phase 4Results posted
• Clinical Efficacy of H.P. Acthar Gel 80 U/ml to Improve the Signs and Symptoms in Subjects With Dry Eye DiseaseCompletedNCT03287635Phase 4Results posted
• Closed-Loop Glucagon Pump for Treatment of Post-Bariatric HypoglycemiaCompletedNCT03255629Phase 1/2Results posted
• Efficacy of Glucagon In the Prevention of Hypoglycemia During Mild ExerciseTerminatedNCT03217175Not applicableResults posted
• A Trial to Evaluate the Immunogenicity of Dasiglucagon and GlucaGen in Patients With Type 1 Diabetes MellitusCompletedNCT03216226Phase 3Results posted
• Acthar Gel for Multiple Sclerosis That Keeps Getting Better and Worse (RRMS)TerminatedNCT03126760Phase 4Results posted
• Glucose Response of G-Pen (Glucagon Injection) in Pediatric T1D PatientsCompletedNCT03091673Phase 3Results posted
• Study of Acthar® Gel (Acthar) for Amyotrophic Lateral Sclerosis (ALS)TerminatedNCT03068754Phase 2/3Results posted
• Adrenocorticotropic Hormone in Membranous NephropathyCompletedNCT03025828Phase 4Results posted
• Effects of ACTHAR on Advanced MRI Surrogate Markers of Disease Activity and on Comprehensive Immune Signature During MS RelapsesTerminatedNCT03021317Phase 4Results posted
• Acthar Gel for Active Systemic Lupus Erythematosus (SLE)CompletedNCT02953821Phase 4Results posted
• CSI-Glucagon for Prevention of Hypoglycemia in Children With Congenital HyperinsulinismCompletedNCT02937558Phase 2Results posted
• Safety and Effectiveness of Acthar Gel in Participants With Rheumatoid ArthritisCompletedNCT02919761Phase 4Results posted
• MRCP: A Reliable, Non Invasive Method for Staging Chronic Pancreatitis in PediatricsCompletedNCT02869893Not applicableResults posted
• A Study of Single or Repeated Doses of Glucagon in Participants With DiabetesCompletedNCT02806973Phase 1Results posted
• A Study of Single and Repeated Doses of Glucagon Administered to Participants With DiabetesTerminatedNCT02806960Phase 1Results posted
• A Study of Glucagon Administered in Different Forms and Routes to Healthy AdultsCompletedNCT02778113Phase 1Results posted
• A Study of Nasal Glucagon in Participants With a Common ColdCompletedNCT02778100Phase 1Results posted
• Open Label Study of Acthar SQ Gel Injection in Patients With Active Anterior UveitisTerminatedNCT02769702Phase 4Results posted
• Study of H.P. ACTHAR Subcutaneous Gelatin (Gel)(Highly Purified Gel Injection) in Uveitis PatientsCompletedNCT02764697Phase 4Results posted
• Pasireotide LAR Therapy of Silent Corticotroph Pituitary TumorsTerminatedNCT02749227Phase 2Results posted
• Delivery of G-Pump™ (Glucagon Infusion) From an OmniPod® to Prevent Hypoglycemia in Post-Bariatric Surgery PatientsCompletedNCT02733588Phase 2Results posted
• Ocular Sarcoidosis Open Label Trial of ACTHAR GelCompletedNCT02725177Not applicableResults posted
• The iLet Introduction Study: A Feasibility Study of the iLet, a Fully Integrated Bihormonal Bionic PancreasTerminatedNCT02701257Not applicableResults posted
• Use of Acthar in Patients With FSGS That Will be Undergoing Renal TransplantationCompletedNCT02683889Phase 3Results posted
• The Use of Mini-dose Glucagon to Prevent Exercise-induced Hypoglycemia in Type 1 DiabetesCompletedNCT02660242Phase 2Results posted
• Safety and Efficacy of G-Pen Compared to Lilly Glucagon for Hypoglycemia Rescue in Adult Type 1 DiabeticsCompletedNCT02656069Phase 3Results posted
• Acthar for Treatment-Resistant or Treatment-Intolerant ProteinuriaCompletedNCT02633046Phase 4Results posted
• Safety and Efficacy Study of SOM230 s.c. in Cluster HeadacheTerminatedNCT02619617Phase 2Results posted
• Treatment of Chronic Antibody-mediated Rejection in Kidney Transplant With ActharTerminatedNCT02546492Phase 4Results posted
• Use of Acthar in Rheumatoid Arthritis (RA) Related FlaresCompletedNCT02541955Phase 4Results posted
• Use of CXCL9 as a Biomarker of Acthar EfficacyTerminatedNCT02523092Phase 4Results posted
• Adrenocorticotropic Hormone (ACTH) Effects on Myelination in Subjects With MSTerminatedNCT02446886Phase 4Results posted
• G-Pen™ for Hypoglycemia Rescue in T1D PatientsCompletedNCT02423980Phase 2Results posted
• Mini-Dose Glucagon to Treat Non-Severe HypoglycemiaCompletedNCT02411578Phase 2Results posted
• Clinical Usability of Nasal Glucagon in Treatment of Hypoglycemia in Children and AdolescentsCompletedNCT02402933Phase 3Results posted
• Cosyntropin Versus Epidural Blood Patch (EBP) for Treatment of Treatment of Post Dural Puncture HeadacheCompletedNCT02394457Phase 4Results posted
• Pasireotide in Patients With Acromegaly Inadequately Controlled With First Generation Somatostatin AnaloguesCompletedNCT02354508Phase 3Results posted
• Stress and the Nervous SystemCompletedNCT02339506Not applicableResults posted
• ACTH for Fatigue in Multiple Sclerosis PatientsCompletedNCT02315872Phase 3Results posted
• Treatment of CNS Sarcoidosis With H.P. Acthar GelCompletedNCT02298491Phase 4Results posted
• Effects of Acthar on Recovery From Cognitive Relapses in MSCompletedNCT02290444Phase 3Results posted
• Pilot Study of ACTH in the Treatment of Immunoglobulin A (IgA) Nephropathy at High Risk of ProgressionCompletedNCT02282930Phase 3Results posted
• Tolerability of Acthar for the Treatment of Multiple Sclerosis in Relapses (TAMS)CompletedNCT02258217Not applicableResults posted
• Efficacy and Safety of H.P. Acthar Gel for the Treatment of Refractory Cutaneous Manifestations of DermatomyositisCompletedNCT02245841Phase 4Results posted
• ACTHar in the Treatment of Lupus NephritisTerminatedNCT02226341Phase 4Results posted
• Pasireotide in Prevention of GI ToxicityCompletedNCT02215070Phase 2Results posted
• Clinical Usability of Intranasal Glucagon in Treatment of HypoglycemiaCompletedNCT02171130Phase 3Results posted
• Secretin Infusion to Prevent Pancreatic Leaks Following Pancreatic ResectionCompletedNCT02160808Phase 2/3Results posted
• Adrenocorticotropic Hormone (ACTH) for Frequently Relapsing and Steroid Dependent Nephrotic SyndromeCompletedNCT02132195Phase 3Results posted
• Safety and Efficacy Study of Mini-Dose Glucagon (G-Pen Mini) in Patients With Type 1 DiabetesCompletedNCT02081014Phase 2Results posted
• PK/PD Study With G-Pump (Glucagon Infusion) in T1DM PatientsCompletedNCT02081001Phase 2Results posted
• Glucagon Use in ColonoscopiesCompletedNCT02078726Phase 4Results posted
• Study of Management of Pasireotide-induced Hyperglycemia in Adult Patients With Cushing's Disease or AcromegalyCompletedNCT02060383Phase 4Results posted
• Acthar as Rescue Therapy for Transplant Glomerulopathy in Kidney Transplant RecipientsTerminatedNCT02057523Phase 4Results posted
• ACTH Gel Therapy in Rheumatoid ArthritisCompletedNCT02030028Not applicableResults posted
• Assessment of Intranasal Glucagon in Children and Adolescents With Type 1 DiabetesCompletedNCT01997411Phase 2/3Results posted
• Efficacy and Safety of Nasal Glucagon for Treatment of Hypoglycemia in AdultsCompletedNCT01994746Phase 3Results posted
• Safety Study of Repeated Doses of Glucagon on Animal Starch in the LiverCompletedNCT01986231Not applicableResults posted
• ACTHAR for Acute Treatment of Rheumatoid Arthritis Patients With Inadequate Response to MethotrexateTerminatedNCT01984268Phase 2Results posted
• Repository Corticotropin Injection To Treat Rheumatoid Arthritis Patients Who Have Failed Three Biologic Therapies.CompletedNCT01966718Phase 4Results posted
• Evaluate the Immunogenicity of a Novel Glucagon FormulationCompletedNCT01959334Phase 3Results posted
• ACTH in Progressive Forms of MSTerminatedNCT01950234Phase 2Results posted
• The Effect of Corticotrophin (ACTH) in Combination With Methotrexate in Newly Diagnosed Rheumatoid Arthritis PatientsCompletedNCT01948388Phase 4Results posted
• Study of the Efficacy and Safety of Pasireotide s.c. +/- Cabergoline in Patients With Cushing's DiseaseTerminatedNCT01915303Phase 2Results posted
• A Study to Explore the Safety and Tolerability of Acthar in Patients With Amyotrophic Lateral SclerosisCompletedNCT01906658Phase 2Results posted

← Hormones overview